Quantcast

Latest Thyroid neoplasm Stories

2010-11-23 12:39:11

CU Medical School researchers help pioneer novel technique Doctors at the University of Colorado School of Medicine were concerned recently when they found a nodule in the thyroid of a 64-year-old Colorado man. They extracted cells from the nodule, hoping to determine whether the man had cancer. But the biopsy results were inconclusive. Even a few months ago, such uncertainty would have likely led to surgery to remove all or part of the thyroid. At least this patient would have faced a tense...

2010-11-16 12:56:00

350,000 Thyroid Cancer Patients Living in the U.S. with 35,000+ New Diagnoses Each Year; Early Detection Through Asking Your Doctor to Check Your Neck is Key NEW YORK, Nov. 16, 2010 /PRNewswire-USNewswire/ -- EHE International and The Light of Life Foundation (LOL) for Thyroid Cancer (www.checkyourneck.com) are pleased to announce the unveiling of a window display at Rockefeller Center reminding Americans to "Check Your Neck" for thyroid cancer. The window will prominently feature images...

2010-09-23 01:00:00

LONDON, Sept. 23 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011. (Logo:...

2010-09-22 09:51:39

(Ivanhoe Newswire) -- The results are in.  After a phase 2 trial, 49 percent of patients with advanced differentiated thyroid cancers responded to treatment using a drug designed to stop tumor blood vessel growth.  The name of drug that has shown the highest response of any treatment to date for advanced thyroid cancer: pazopanib.  The estimated time two-thirds of these patients are likely to have a response to the drug: 1 year or longer.  With the incidence of thyroid...

2010-09-20 18:39:44

Given potential side effects, patients with slow-growing thyroid cancer should not use pazopanib The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology. VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Keith Bible describing the research, are available on the...

2010-09-15 08:00:00

SOUTH SAN FRANCISCO, Calif., Sept. 15 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, announced that initial data from its large-scale, prospective, multi-center clinical trial were presented today at the 14th International Thyroid Congress, held in Paris, France. The findings showed that the company's molecular test classified inconclusive thyroid nodule fine needle aspirates (FNA) as benign with a high degree of...

2010-08-25 14:23:33

To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer. So, with the...

2010-07-15 13:57:38

Procedure removes diseased gland without leaving a scar UC Irvine Healthcare is the first medical center on the West Coast and the only one in California to perform robotic thyroidectomies, a procedure that removes the diseased gland without leaving a visible scar on the neck. Dr. Jason Kim, associate clinical professor of otolaryngology and a head and neck cancer specialist, has performed robotic-assisted surgery using the daVinci Surgical System on three patients with thyroid tumors. "We're...

2010-06-07 08:14:00

LONDON, June 7, 2010 /PRNewswire-FirstCall/ -- Results from ZETA, a phase III study in patients with advanced medullary thyroid cancer (MTC), showed that treatment with the investigational drug vandetanib significantly extended Progression Free Survival (PFS), the primary endpoint of the study, by demonstrating a 54% reduction in the rate of progression compared to placebo (HR=0.46, p=0.0001). The results of the ZETA study were presented today at the American Society of Clinical Oncology...

2010-05-27 10:32:09

Researchers at Mayo Clinic say a nationwide clinical trial is also planned Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago. Mayo oncologists say this new approach reflects the need to aggressively treat metastasis even when this rare...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related